Phase Inpatient Withdrawal Programme for Long-Term Opioid Use in Non-Cancer Pain,” published in the March 2025 issue of ...

The Ninth District’s Medical Examiner’s Office released data today showing opioid overdose deaths decreased in Orange County ...

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid ...

When MultiCare peer support liaison Chandelle Gill speaks to a patient about their addiction, she can see herself.

Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal phase II clinical trial, offering hope to newborns with Neonatal Opioid Withdrawal Syndrome ...

What you need to know about opioid overdose reversal drug nalmefene’s risks, effectiveness and clinical concerns ...

People who are incarcerated at the Weber County Correctional Facility and struggling with opioid use disorder now have access ...

Purdue Pharma, manufacturer of the prescription painkiller opioid OxyContin ... and later became addicted and babies born with withdrawal symptoms after being exposed to the drug in the womb.

Philly’s opioid addiction crisis is constantly evolving. Local health care workers and researchers explain some of the latest ...

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...

Patients who struggle with opioid addiction and who are treated by California emergency department physicians are remarkably ...